NASDAQ: LSTA - Lisata Therapeutics, Inc.

Altı ay boyunca karlılık: -21.67%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı Lisata Therapeutics, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases.

daha fazla ayrıntı
Its product candidates include LSTA1, which is in Phase 1b/2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; HONEDRA, a recipient of SAKIGAKE designation critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and LSTA201, a CD34+ cell therapy for the treatment of chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. The company was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. on September 15, 2022. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 1999-03-01
ISIN US1280583022
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.lisata.com
Цена ао 2.43
Günlük fiyat değişimi: -2.51% (2.4104)
Haftalık fiyat değişimi: -1.26% (2.38)
Aylık fiyat değişimi: -1.67% (2.39)
3 ayda fiyat değişimi: -22.19% (3.0201)
Altı ayda fiyat değişimi: -21.67% (3)
Yıllık fiyat değişimi: -24.68% (3.12)
3 yılda fiyat değişimi: +201.28% (0.78)
5 yılda fiyat değişimi: -0.4237% (2.36)
Yılbaşından bu yana fiyat değişimi: -13.28% (2.71)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 0.1067 10
P/BV 0.477 10
P/E 0 0
EV/EBITDA -0.0219 0
Toplam: 6.25

Yeterlik

İsim Anlam Seviye
ROA, % -38.1 0
ROE, % -43.28 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.012 10
Toplam: 9.8

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 727.43 10
karlılık Ebitda, % 32.22 5
karlılık EPS, % -91.16 0
Toplam: 3.4
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Bml Capital Management, LLC 269839 3.25
Vanguard Group Inc 176965 2.13
Renaissance Technologies, LLC 97222 1.17
Blackrock Inc. 56250 0.68
Geode Capital Management, LLC 43390 0.52
Susquehanna International Group, LLP 33749 0.41
State Street Corporation 14348 0.17
Citadel Advisors Llc 14131 0.17
Cook Wealth Management Group LLC 12175 0.15
HighTower Advisors, LLC 10044 0.12



Süpervizör İş unvanı Ödeme Doğum yılı
Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D. President, CEO & Director 1.16M 1957 (68 yıllar)
Dr. Kristen K. Buck M.D. Executive VP of R&D and Chief Medical Officer 938.42k 1974 (51 yıl)
Mr. James Nisco Senior VP of Finance, Treasurer, CAO & Principal Financial and Accounting Officer N/A 1971 (54 yıl)
Mr. Tariq Imam Vice President of Business Development & Operations and Corporate Counsel N/A
Mr. Gregory S. Berkin Chief Information Officer N/A
Mr. John D. Menditto Vice President of Investor Relations & Corporate Communications N/A
Ms. Gail Holler Vice President of Human Resources N/A 1959 (66 yıllar)
Dr. William K. Sietsema Ph.D. Vice President of Global Regulatory Affairs 350.55k 1956 (69 yıllar)

Adres: United States, Basking Ridge. NJ, 110 Allen Road - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.lisata.com